Westside Investment Management, Inc. Biogen Inc. Transaction History

Westside Investment Management, Inc.

$437 Billion
Q2 2024

A detailed history of Westside Investment Management, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Westside Investment Management, Inc. holds 2,414 shares of BIIB stock, worth $419,529. This represents 0.13% of its overall portfolio holdings.

Number of Shares

2,414

Previous 2,154 12.07%

Holding current value

$419,529

Previous $464 Million 20.68%

% of portfolio

0.13%

Previous 0.11%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 17, 2024	BUY	$190.52 - $236.72 $49,535 - $61,547	260 Added 12.07%	2,414 $560 Million
Q1 2024 Apr 19, 2024	BUY	$212.02 - $267.71 $10,601 - $13,385	50 Added 2.38%	2,154 $464 Million
Q3 2023 Nov 15, 2023	BUY	$253.3 - $285.89 $2,533 - $2,858	10 Added 0.48%	2,104 $541 Million
Q1 2023 May 17, 2023	SELL	$256.56 - $292.34 $12,828 - $14,616	-50 Reduced 2.33%	2,094 $582 Million
Q4 2022 Jan 31, 2023	BUY	$252.44 - $306.72 $36,351 - $44,167	144 Added 7.2%	2,144 $259 Million
Q3 2022 Nov 09, 2022	BUY	$194.69 - $268.46 $9,734 - $13,422	50 Added 2.56%	2,000 $254 Million
Q1 2022 Apr 25, 2022	BUY	$193.77 - $244.14 $19,377 - $24,414	100 Added 5.41%	1,950 $410,000
Q4 2021 Feb 15, 2022	BUY	$223.92 - $287.77 $31,348 - $40,287	140 Added 8.19%	1,850 $443,000
Q3 2021 Oct 27, 2021	BUY	$282.99 - $369.05 $59,427 - $77,500	210 Added 14.0%	1,710 $483,000
Q2 2021 Jul 28, 2021	SELL	$259.0 - $414.71 $139,860 - $223,943	-540 Reduced 26.47%	1,500 $519,000
Q4 2020 Jan 15, 2021	BUY	$236.26 - $355.63 $96,866 - $145,808	410 Added 25.15%	2,040 $499,000
Q3 2020 Oct 14, 2020	BUY	$264.77 - $305.71 $92,669 - $106,998	350 Added 27.34%	1,630 $462,000
Q2 2020 Jul 21, 2020	SELL	$258.66 - $342.55 $101,653 - $134,622	-393 Reduced 23.49%	1,280 $342,000
Q1 2020 Apr 16, 2020	SELL	$268.85 - $341.04 $189,001 - $239,751	-703 Reduced 29.59%	1,673 $529,000
Q2 2019 Jul 24, 2019	SELL	$219.29 - $241.72 $19,078 - $21,029	-87 Reduced 3.53%	2,376 $555,000
Q4 2018 Feb 05, 2019	SELL	$278.5 - $352.75 $88,006 - $111,469	-316 Reduced 11.37%	2,463 $741,000
Q3 2018 Nov 08, 2018	SELL	$293.51 - $383.83 $29,057 - $37,999	-99 Reduced 3.44%	2,779 $980 Million
Q2 2018 Aug 13, 2018	SELL	$257.52 - $306.91 $2,317 - $2,762	-9 Reduced 0.31%	2,878 $0
Q1 2018 Apr 16, 2018	SELL	$260.13 - $367.91 $30,435 - $43,045	-117 Reduced 3.89%	2,887 $0
Q4 2017 Feb 15, 2018	SELL	$307.64 - $344.58 $2,153 - $2,412	-7 Reduced 0.23%	3,004 $0
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $6,185 - $7,253	22 Added 0.74%	3,011 $0
Q2 2017 Aug 15, 2017	BUY	N/A	2,989	2,989 $0

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Westside Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Westside Investment Management, Inc. with notifications on news.

Account

Westside Investment Management, Inc. Biogen Inc. Transaction History